Literature DB >> 11850068

Predominance of trisomy 1q in myelodysplastic syndromes in Korea: is there an ethnic difference? A 3-year multi-center study.

Dong Soon Lee1, Sun Hee Kim, Eul Ju Seo, Chan Jung Park, Hyun Sook Chi, Eun Kyoung Ko, Byoung Hak Yoon, Wo Ho Kim, Han Ik Cho.   

Abstract

A predominance of total or partial chromosomal losses and the rarity of translocations are characteristics of myelodysplastic syndrome (MDS), and 5q,-5, -7 and +8 are known to be the most predominant chromosomal changes. To investigate whether the incidence and the pattern of chromosomal changes in MDS varies by location in Korea, we reviewed the cytogenetic results of 205 MDS cases from three medical centers. Distribution of MDS subtypes and the incidence of chromosomal aberration (44.8%) of MDS in Korea were similar to those found in other countries, however, their patterns were different. Translocations (40.4%) predominated over partial or total deletions (36.3%) in Korea. The most common abnormalities in MDS were trisomy 8, trisomy 1q, -5/5q-, and -7/7q-, which occurred in 18(19.5%), 14(15.2%), 12(13.0%), and 11(11.9%) patients, respectively. It is of note that trisomy 1q, which is rarely reported in hematologic malignancies, was the second most common change associated with MDS in Korea, and that structural anomalies of chromosomes 1(19.6%) exceeded that of chromosome 5(15.2%). The most common sole anomalies were trisomy 8(7.6%) and 14(78%) of 18 cases with chromosome 1 anomalies accompanied by other chromosomal abnormalities, suggesting that the changes of chromosome 1 may be evolutionary events rather than sporadic events. In conclusion, trisomy 1q and trisomy 8 predominate in Korean MDS, suggesting the likelihood of ethnic differences.

Entities:  

Mesh:

Year:  2002        PMID: 11850068     DOI: 10.1016/s0165-4608(01)00533-7

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  6 in total

Review 1.  The myelodysplastic syndromes: morphology, risk assessment, and clinical management (2002).

Authors:  John M Bennett; Peter A Kouides; Stephen J Forman
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

Review 2.  What's all the fuss about? facts and figures about bone marrow failure and conditions.

Authors:  Sudipto Mukherjee; Mikkael A Sekeres
Journal:  Curr Hematol Malig Rep       Date:  2012-12       Impact factor: 3.952

3.  Mimicker of necrotising fasciitis with systemic inflammatory response syndrome: recurrent necrotising Sweet's syndrome associated with chronic myelogenous leukaemia.

Authors:  Kensuke Nakanishi; Mitsuyo Kinjo
Journal:  BMJ Case Rep       Date:  2016-03-31

4.  Myelodysplastic syndrome in an infant with constitutional pure duplication 1q41-qter.

Authors:  Hirokazu Morokawa; Motoko Kamiya; Keiko Wakui; Mikiko Kobayashi; Takashi Kurata; Kazuyuki Matsuda; Rie Kawamura; Hiroyuki Kanno; Yoshimitsu Fukushima; Yozo Nakazawa; Tomoki Kosho
Journal:  Hum Genome Var       Date:  2018-05-21

5.  Prognostic value of integrated cytogenetic, somatic variation, and copy number variation analyses in Korean patients with newly diagnosed multiple myeloma.

Authors:  Nuri Lee; Sung-Min Kim; Youngeun Lee; Dajeong Jeong; Jiwon Yun; Sohee Ryu; Sung-Soo Yoon; Yong-Oon Ahn; Sang Mee Hwang; Dong Soon Lee
Journal:  PLoS One       Date:  2021-02-05       Impact factor: 3.240

6.  Short telomere length and its correlation with gene mutations in myelodysplastic syndrome.

Authors:  Sang Mee Hwang; Seon Young Kim; Jung Ah Kim; Hee-Sue Park; Si Nae Park; Kyongok Im; Kwantae Kim; Sung-Min Kim; Dong Soon Lee
Journal:  J Hematol Oncol       Date:  2016-07-28       Impact factor: 17.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.